Literature for C111.001

Summary Alignment Sequences Sequence features Distribution Structure Literature Substrates

(Topics flags: S Structure, A Assay, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2023
  1. Desage,S., Leuci,A., Enjolras,N., Holle,L.A., Singh,S., Delavenne,X., Wolberg,A.S., Biswas,A. and Dargaud,Y.
    Characterization of a recombinant factor IX molecule fused to coagulation factor XIII-B subunit
    Haemophilia29, 1483-1489. PubMed  Europe PubMed DOI
  2. Osaki,T., Souri,M., Ozawa,T., Muraguchi,A. and Ichinose,A.
    Epitope analysis of human monoclonal antibodies from a patient with autoimmune factor XIII deficiency reveals their inhibitory mechanisms
    FEBS Lett597, 1275-1289. PubMed  Europe PubMed DOI
  3. 2022
  4. De Simone,I., Baaten,C.C.F.M., Jandrot-Perrus,M., Gibbins,J.M., ten Cate,H., Heemskerk,J.W.M., Jones,C.I. and van der Meijden,P.E.J.
    Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1
    Int J Mol Sci23, PubMed  Europe PubMed DOI
  5. 2021
  6. Leitner,M., Buchold,C., Pasternack,R., Binder,N.B. and Moore,G.W.
    Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity
    Int J Mol Sci22, PubMed  Europe PubMed DOI
  7. 2020
  8. Anokhin,B.A., Dean,W.L., Smith,K.A., Flick,M.J., Ariens,R.A.S., Philippou,H. and Maurer,M.C.
    Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A
    FEBS J287, 452-464. PubMed  Europe PubMed DOI
  9. Csoban-Szabo,Z., Fesus,L. and Kiraly,R.
    Protein-peptide based assay for the characterization of human blood coagulation factor XIII-A isopeptidase activity
    Anal Biochem113699-113699. PubMed  Europe PubMed DOI  A
  10. Leitner,M., Buchold,C., Pasternack,R. and Binder,N.B.
    Feasibility of an automated coagulation factor XIIIa test using its isopeptidase activity
    Anal Biochem113757-113757. PubMed  Europe PubMed DOI  A
  11. Pasternack,R., Buchold,C., Jahnig,R., Pelzer,C., Sommer,M., Heil,A., Florian,P., Nowak,G., Gerlach,U. and Hils,M.
    Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)
    J Thromb Haemost18, 191-200. PubMed  Europe PubMed DOI
  12. Pedersen,N.B., Stolberg,C.R., Mundbjerg,L.H., Juhl,C.B., Gram,B., Funch-Jensen,P., de Maat,M.P.M., Munster,A.B. and Bladbjerg,E.M.
    Reductions in plasmin inhibitor and fibrinogen predict the improved fibrin clot lysis 6 months after obesity surgery
    Clin Obese12397-e12397. PubMed  Europe PubMed DOI
  13. Schmitz,T., Bauml,C.A. and Imhof,D.
    Inhibitors of blood coagulation factor XIIIa
    Anal Biochem113708-113708. PubMed  Europe PubMed DOI  I
  14. 2017
  15. Anokhin,B.A., Stribinskis,V., Dean,W.L. and Maurer,M.C.
    Activation of factor XIII is accompanied by a change in oligomerization state
    FEBS J284, 3849-3861. PubMed  Europe PubMed DOI
  16. Shubin,N.J., Glukhova,V.A., Clauson,M., Truong,P., Abrink,M., Pejler,G., White,N.J., Deutsch,G.H., Reeves,S.R., Vaisar,T., James,R.G. and Piliponsky,A.M.
    Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation
    J Allergy Clin Immunol139, 323-334. PubMed  Europe PubMed DOI
  17. 2015
  18. Avery,C.A., Pease,R.J., Smith,K., Boothby,M., Buckley,H.M., Grant,P.J. and Fishwick,C.W.
    (+/-) cis-Bisamido epoxides: a novel series of potent FXIII-A inhibitors
    Eur J Med Chem98, 49-53. PubMed  Europe PubMed DOI  I
  19. 2013
  20. Heil,A., Weber,J., Buchold,C., Pasternack,R. and Hils,M.
    Differences in the inhibition of coagulation factor XIII-A from animal species revealed by Michael acceptor- and thioimidazol based blockers
    Thromb Res131, e214-e222. PubMed  Europe PubMed DOI  I
  21. Schroeder,V. and Kohler,H.P.
    New developments in the area of factor XIII
    J Thromb Haemost11, 234-244. PubMed  Europe PubMed DOI  V
  22. 2011
  23. Jadhav,M.A., Lucas,R.C., Goldsberry,W.N. and Maurer,M.C.
    Design of factor XIII V34X activation peptides to control ability to interact with thrombin mutants
    Biochim Biophys Acta1814, 1955-1963. PubMed  Europe PubMed DOI
  24. 2002
  25. Fesus,L. and Piacentini,M.
    Transglutaminase 2: an enigmatic enzyme with diverse functions
    Trends Biochem Sci27, 534-539. PubMed  Europe PubMed DOI
  26. 1999
  27. Makarova,K.S., Aravind,L. and Koonin,E.V.
    A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases
    Protein Sci8, 1714-1719. PubMed  Europe PubMed DOI
  28. 1998
  29. [YEAR:15-5-1998]Jenner,L., Husted,L., Thirup,S., Sottrup-Jensen,L. and Nyborg,J.
    Crystal structure of the receptor-binding domain of alpha2-macroglobulin
    Structure6, 595-604. PubMed  Europe PubMed  S
  30. 1994
  31. Pedersen,L.C., Yee,V.C., Bishop,P.D., Le Trong,I., Teller,D.C. and Stenkamp,R.E.
    Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules
    Protein Sci3, 1131-1135. PubMed  Europe PubMed DOI  S
  32. 1993
  33. Lorand,L., Jeong,J.M., Radek,J.T. and Wilson,J.
    Human plasma factor XIII: subunit interactions and activation of zymogen
    Methods Enzymol222, 22-35. PubMed  Europe PubMed DOI
  34. 1990
  35. Ichinose,A., Bottenus,R.E. and Davie,E.W.
    Structure of transglutaminases
    J Biol Chem265, 13411-13414. PubMed  Europe PubMed  V
  36. 1988
  37. [YEAR:16-6-1988]Lynch,G.W. and Pfueller,S.L.
    Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease
    Thromb Haemost59, 372-377. PubMed  Europe PubMed
  38. 1986
  39. Takahashi,N., Takahashi,Y. and Putnam,F.W.
    Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta
    Proc Natl Acad Sci U S A83, 8019-8023. PubMed  Europe PubMed
  40. 1983
  41. [YEAR:21-3-1983]Ichinose,A., Tamaki,T. and Aoki,N.
    Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin
    FEBS Lett153, 369-371. PubMed  Europe PubMed DOI
  42. 1982
  43. [YEAR:25-12-1982]Tamaki,T. and Aoki,N.
    Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor
    J Biol Chem257, 14767-14772. PubMed  Europe PubMed
  44. 1981
  45. Mortensen,S.B., Sottrup-Jensen,L., Hansen,H.F., Rider,D., Petersen,T.E. and Magnusson,S.
    Sequence location of a putative transglutaminase crosslinking site in human alpha2-macroglobulin
    FEBS Lett129, 314-317. PubMed  Europe PubMed